NASDAQ : EDSA
Edesa Biotech, Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 2.57 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 34.72M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 5.55M | 4.24M | 4.13M | 4.43M | 5.04M | 5.73M |
| Research & Development | 9.08M | 3.67M | 2.88M | 4.79M | 13.34M | 17.95M |
| Operating Expenses | 14.63M | 7.91M | 7.01M | 9.22M | 18.37M | 23.68M |
| Operating Income | -14.63M | -7.91M | -7.01M | -9.22M | -18.37M | -23.68M |
| Interest & Investment Income | 1.02K | 2.56K | 153.50K | 289.85K | 63.52K | 11.16K |
| Currency Exchange Gain (Loss) | 2.82K | -59.61K | -21.04K | -21.74K | -21.11K | -13.02K |
| EBT Excluding Unusual Items | -14.89M | -7.97M | -6.88M | -8.95M | -18.33M | -23.68M |
| Other Unusual Items | 783.89K | 783.89K | 713.04K | 581.04K | 780.26K | 10.34M |
| Pretax Income | -14.10M | -7.18M | -6.17M | -8.37M | -17.55M | -13.34M |
| Income Tax Expense | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 |
| Net Income | -14.10M | -7.19M | -6.17M | -8.37M | -17.55M | -13.34M |
| Net Income to Common | -14.10M | -7.19M | -6.17M | -8.37M | -17.55M | -13.34M |
| Shares Outstanding (Basic) | 8.14M | 5.68M | 3.20M | 2.86M | 2.10M | 1.73M |
| Shares Outstanding (Diluted) | 8.14M | 5.68M | 3.20M | 2.86M | 2.10M | 1.73M |
| EPS (Basic) | -1.73 | -1.27 | -1.93 | -2.93 | -8.37 | -7.73 |
| EPS (Diluted) | -1.73 | -1.27 | -1.93 | -2.93 | -8.37 | -7.73 |
| Free Cash Flow | -8.91M | -7.32M | -4.89M | -6.64M | -12.28M | -13.67M |
| Free Cash Flow Per Share | -1.09 | -1.29 | -1.53 | -2.32 | -5.86 | -7.92 |
| EBITDA | -14.53M | -7.79M | -6.83M | -9.12M | -18.26M | -23.57M |
| D&A For EBITDA | 102.84K | 119.27K | 186.05K | 105.50K | 108.16K | 109.50K |
| EBIT | -14.63M | -7.91M | -7.01M | -9.22M | -18.37M | -23.68M |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.33M | 10.79M | 1.04M | 5.36M | 7.09M | 7.84M |
| Cash & Short-Term Investments | 10.33M | 10.79M | 1.04M | 5.36M | 7.09M | 7.84M |
| Other Receivables | 228.05K | 642.87K | 270.91K | 626.54K | 1.26M | 3.30M |
| Receivables | 228.05K | 642.87K | 270.91K | 626.54K | 1.26M | 3.30M |
| Prepaid Expenses | 219.71K | 77.84K | 367.39K | 448.91K | 745.54K | 948.64K |
| Total Current Assets | 10.78M | 11.51M | 1.68M | 6.44M | 9.09M | 12.09M |
| Property, Plant & Equipment | 18.36K | 100.08K | 31.16K | 111.56K | ||
| Other Intangible Assets | 1.90M | 1.98M | 2.08M | 2.18M | 2.28M | 2.38M |
| Other Long-Term Assets | 39.12K | 39.97K | 41.15K | 173.49K | 171.46K | |
| Total Assets | 12.72M | 13.53M | 3.81M | 8.89M | 11.58M | 14.58M |
| Accounts Payable | 3.91M | 1.08M | 1.81M | 1.75M | 2.12M | 1.38M |
| Current Portion of Leases | 19.87K | 74.71K | 18.98K | 78.81K | ||
| Total Current Liabilities | 3.91M | 1.08M | 1.83M | 1.82M | 2.14M | 1.46M |
| Long-Term Leases | 19.77K | 20.51K | ||||
| Other Long-Term Liabilities | 43.66K | 47.20K | ||||
| Total Liabilities | 3.91M | 1.08M | 1.83M | 1.84M | 2.18M | 1.53M |
| Common Stock | 62.42M | 54.52M | 47.24M | 46.64M | 42.47M | 34.89M |
| Additional Paid-In Capital | 16.04M | 14.75M | 13.58M | 13.04M | 11.18M | 4.87M |
| Retained Earnings | -77.90M | -65.91M | -58.59M | -52.42M | -44.04M | -26.50M |
| Comprehensive Income & Other | -158.54K | -165.77K | -242.61K | -214.65K | -213.60K | -205.26K |
| Total Common Equity | 398.97K | 3.19M | 1.98M | 7.05M | 9.39M | 13.06M |
| Shareholders' Equity | 8.81M | 12.45M | 1.98M | 7.05M | 9.39M | 13.06M |
| Total Liabilities & Equity | 12.72M | 13.53M | 3.81M | 8.89M | 11.58M | 14.58M |
| Total Debt | 19.87K | 94.49K | 18.98K | 99.32K | ||
| Net Cash (Debt) | 10.33M | 10.79M | 1.02M | 5.27M | 7.07M | 7.74M |
| Net Cash Per Share | 1.27 | 1.90 | 0.32 | 1.84 | 3.37 | 4.49 |
| Filing Date Shares Outstanding | 9.64M | 8.33M | 3.47M | 3.16M | 2.76M | 1.93M |
| Total Common Shares Outstanding | 9.63M | 7.14M | 3.25M | 3.08M | 2.38M | 1.90M |
| Working Capital | 6.87M | 10.43M | -157.21K | 4.61M | 6.95M | 10.63M |
| Book Value Per Share | 0.04 | 0.45 | 0.61 | 2.29 | 3.95 | 6.88 |
| Tangible Book Value | -1.50M | 1.21M | -97.69K | 4.87M | 7.11M | 10.68M |
| Tangible Book Value Per Share | -0.16 | 0.17 | -0.03 | 1.58 | 2.99 | 5.62 |
| Machinery | 52.55K | 52.21K | 48.84K |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -14.10M | -7.19M | -6.17M | -8.37M | -17.55M | -13.34M |
| Depreciation & Amortization | 102.84K | 119.27K | 186.05K | 183.47K | 118.19K | 118.79K |
| Stock-Based Compensation | 1.84M | 729.64K | 537.49K | 1.25M | 2.26M | 3.20M |
| Other Operating Activities | -14.77K | |||||
| Change in Accounts Receivable | 52.76K | -377.99K | 356.34K | 562.77K | 2.03M | -3.23M |
| Change in Accounts Payable | 3.31M | -715.50K | 17.59K | -556.27K | 882.84K | -124.72K |
| Change in Other Net Operating Assets | -110.63K | 107.83K | 197.14K | 301.50K | -19.50K | -281.36K |
| Operating Cash Flow | -8.91M | -7.32M | -4.89M | -6.64M | -12.28M | -13.66M |
| Capital Expenditures | -5.66K | -6.15K | ||||
| Investing Cash Flow | -5.66K | -6.15K | ||||
| Long-Term Debt Repaid | -29.53K | |||||
| Net Debt Issued (Repaid) | -29.53K | |||||
| Issuance of Common Stock | 7.22M | 7.72M | 729.39K | 5.12M | 11.96M | 14.36M |
| Other Financing Activities | -238.46K | -567.56K | -107.82K | -285.44K | -328.06K | -188.37K |
| Financing Cash Flow | 6.98M | 17.03M | 592.03K | 4.83M | 11.63M | 14.17M |
| Foreign Exchange Rate Adjustments | -101.41K | 46.22K | -25.90K | 76.85K | -93.01K | 121.90K |
| Net Cash Flow | -2.03M | 9.75M | -4.32M | -1.73M | -748.34K | 625.56K |
| Free Cash Flow | -8.91M | -7.32M | -4.89M | -6.64M | -12.28M | -13.67M |
| Free Cash Flow Per Share | -1.09 | -1.29 | -1.53 | -2.32 | -5.86 | -7.92 |
| Levered Free Cash Flow | -4.01M | -4.91M | -3.16M | -3.78M | -6.12M | -14.93M |
| Unlevered Free Cash Flow | -4.01M | -4.91M | -3.16M | -3.78M | -6.12M | -14.93M |
| Change in Working Capital | 3.25M | -985.65K | 571.07K | 308.00K | 2.89M | -3.64M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 34.99M | 17.38M | 14.45M | 13.33M | 14.25M | 97.83M |
| Enterprise Value | 24.66M | 14.24M | 12.45M | 6.99M | 1.48M | 89.89M |
| Last Close Price | 2.57 | 2.47 | 4.45 | 4.42 | 6.45 | 51.66 |
| Forward PE | 0.88 | 0.88 | 0.88 | 56.67 | ||
| PB Ratio | 62.05 | 1.40 | 7.29 | 1.89 | 1.52 | 7.49 |
| P/TBV Ratio | 14.32 | 2.74 | 2.00 | 9.16 | ||
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | ||
| Net Debt / Equity Ratio | -1.17 | -0.87 | -0.51 | -0.75 | -0.75 | -0.59 |
| Net Debt / EBITDA Ratio | 0.71 | 1.39 | 0.15 | 0.58 | 0.39 | 0.33 |
| Net Debt / FCF Ratio | 1.16 | 1.47 | 0.21 | 0.79 | 0.58 | 0.57 |
| Quick Ratio | 2.70 | 10.60 | 0.71 | 3.29 | 3.90 | 7.64 |
| Current Ratio | 2.76 | 10.68 | 0.91 | 3.53 | 4.25 | 8.29 |
| Return on Equity (ROE) | -122.93% | -99.57% | -136.66% | -101.88% | -156.34% | -120.39% |
| Return on Assets (ROA) | -66.43% | -57.02% | -69.02% | -56.33% | -87.78% | -116.79% |
| Return on Capital Employed (ROCE) | -166.00% | -63.50% | -354.10% | -130.50% | -194.70% | -180.40% |
| Earnings Yield | -66.87% | -41.34% | -42.70% | -62.82% | -123.19% | -13.64% |
| FCF Yield | -25.65% | -42.12% | -33.84% | -49.78% | -86.24% | -13.98% |
| Buyback Yield / Dilution | -72.33% | -77.54% | -11.84% | -36.37% | -21.50% | -40.32% |